Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Interest & Investment Income (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Interest & Investment Income for 3 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 12.64% to $5.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.4 million, a 20.81% decrease, with the full-year FY2025 number at $21.4 million, down 20.81% from a year prior.
  • Interest & Investment Income was $5.3 million for Q4 2025 at Nuvation Bio, down from $6.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $7.1 million in Q2 2024 to a low of $4.8 million in Q2 2025.
  • A 3-year average of $6.1 million and a median of $6.1 million in 2023 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: skyrocketed 43.2% in 2024, then plummeted 33.09% in 2025.
  • Nuvation Bio's Interest & Investment Income stood at $7.0 million in 2023, then fell by 13.68% to $6.1 million in 2024, then fell by 12.64% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Interest & Investment Income are $5.3 million (Q4 2025), $6.0 million (Q3 2025), and $4.8 million (Q2 2025).